Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$9.80 – $13.38
83% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $431.6M | $398.1M | $363.9M | $398.6M | $424.6M | $445.6M | $331.5M | $258.6M |
| Cost of revenue | $132.9M | $128.4M | $120.9M | $130.0M | $143.9M | $282.9M | $111.6M | $160.4M |
| Gross profit | $298.7M | $269.7M | $242.9M | $268.6M | $280.6M | $162.6M | $219.9M | $98.2M |
| Gross margin | 69.2% | 67.7% | 66.8% | 67.4% | 66.1% | 36.5% | 66.3% | 38.0% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $73.4M | $111.3M | $67.8M | $77.4M | $46.9M | $67.1M | $61.6M | $47.5M |
| EBITDA | $93.4M | $115.6M | $97.5M | $103.4M | $43.1M | $77.9M | $82.6M | $59.4M |
| Net income | $20.9M | $59.7M | $37.4M | $46.5M | $12.3M | $18.5M | $73.5M | $21.1M |
| Net margin | 4.8% | 15.0% | 10.3% | 11.7% | 2.9% | 4.2% | 22.2% | 8.2% |
| EPS (diluted) | 0.63 | 1.61 | 1.20 | 1.49 | 0.42 | 0.73 | 3.06 | 1.08 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $272M | $1.98 | $1.96–$1.99 | 1 |
| 2027 | $277M | $1.35 | $1.34–$1.36 | 1 |
| 2028 | $277M | $1.99 | $1.98–$2.00 | 1 |
Forward consensus · source: Financial Modeling Prep
MEDICAL FACILITIES CORP
No one on the platform currently holds MFCSF.
No tracked institution reports a position in MFCSF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-06-30 | $0.0900 | 2026-07-15 |
| 2026-03-31 | $0.0900 | 2026-04-15 |
| 2025-12-31 | $0.0900 | 2026-01-15 |
| 2025-09-29 | $0.0900 | 2025-10-15 |
| 2025-06-30 | $0.0900 | 2025-07-15 |
| 2025-03-31 | $0.0900 | 2025-04-15 |
| 2024-12-31 | $0.0900 | 2025-01-15 |
| 2024-09-27 | $0.0900 | 2024-10-15 |
| 2024-06-28 | $0.0900 | 2024-07-15 |
| 2024-03-27 | $0.0805 | 2024-04-15 |
No one on the platform has traded MFCSF yet.
| +0.00% |
| $2M |
| — |
| GNFTFGenfit S.a. | $10.75 | +0.00% | $539M | — |
| JWCTFJW (Cayman) Therapeutics Co. Ltd | $0.24 | +0.00% | $99M | — |
Source: Financial Modeling Prep · peers by sector/industry
| 2023-12-28 |
| $0.0805 |
| 2024-01-15 |
| 2023-09-28 | $0.0805 | 2023-10-16 |
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 4.0× earnings vs its 8.8× historical median P/E.
Fair value ≈ $27.86 · price $12.76 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.